IO Biotech share price logo

IO Biotech

OTC: IOBTQ

$0.00

Live

as on

IO Biotech Stock Performance

as on October 22, 2026 at 6:21 am IST

  • Day's Low

    Day's High

    $0.01
    $0.01
    downward going graph

    -9900.00%

    Downside

    9900.00%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    downward going graph

    100.00%

    Downside

    -100.00%

    Upside

    downward going graph

IO Biotech share price movements today

Previous Close
$0.00
Open
$0.01
Volume
10.0K
Market Cap
$7.2K
Day's Low - High
$0.01 - $0.01

IO Biotech Historical Returns

1 Month Return
-50 %
3 Month Return
-90 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

IO Biotech Stock Fundamentals & Key Indicators

Check IO Biotech market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$7.2K

EPS (TTM)

-1.35

Dividend Yield

0.00%

PE Ratio (TTM)

-0.01

Industry PE ratio

0.00

PEG Ratio

-0.00

Return On Equity TTM

-465.36%

IO Biotech stock Key Stats

Compare market cap, revenue, PE, and other key metrics of IO Biotech with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$7.2KNA-0.010.00%0.00%

Indian Investors' Interest in IO Biotech Stock

Search interest for IO Biotech Stock has increased by 885% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:885% versus previous 30 day period

IO Biotech Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-21
-23
-28
-20
-21
-26
-26
-22
-23
-19
EBITDA
-20
-21
-25
-18
-20
-23
-30
-22
-25
-8
Interest Expense
-
-
-
-
-
-
-
-
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-20
-22
-25
-19
-20
-23
-30
-22
-26
-10
Income Tax Expense
0
0
0
0
0
0
0
0
0
-1
Net Income
-21
-21
-26
-19
-20
-24
-31
-22
-26
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

IO Biotech Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
Gross Profit
-
-
-
0
0
0
Operating Income
-9
-10
-41
-71
-91
-95
EBITDA
0
-12
-67
-69
-84
-93
Interest Expense
0
0
0
0
-
-
Depreciation
9
-
0
0
0
0
Income Before Tax
-10
-12
-67
-70
-85
-94
Income Tax Expense
-
-
0
1
0
1
Net Income
-10
-12
-67
-71
-86
-95
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

IO Biotech Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-21
-21
-26
-19
-20
-24
-31
-22
-26
-8
Operating Cash Flow
-18
-15
-22
-24
-16
-20
-19
-23
-19
-18
Investing Cash Flow
0
0
0
0
0
0
0
0
0
0
Financing Cash Flow
-
71
0
-
-
-
-
-
11
21
Change in Cash
-18
55
-22
-25
-17
-20
-20
-22
-8
2

IO Biotech Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Mar 2022
Dec 2022
Dec 2023
Dec 2024
Net Income
-10
-12
-67
-71
-86
-95
Operating Cash Flow
-8
-9
-40
-59
-71
-82
Investing Cash Flow
-
-
0
0
0
0
Financing Cash Flow
9
5
252
-
71
-
Change in Cash
0
-4
208
-68
0
-83

Global Institutional Holdings in IO Biotech

Check out the Institutions with significant holdings in IO Biotech.

Funds
Holdings
Fidelity Concord Street Trust
0.05%

About IO Biotech

IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops immune-modulating cancer therapies based on the T-win technology platform. The company's lead product candidate, IO102-IO103, which is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death-ligand (PD-L1) that is in phase 2 clinical trial to treat melanoma, as well as in phase 1 clinical trial to treat lung, head and neck, bladder, and melanoma cancer. It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. The company was incorporated in 2014 and is based in Copenhagen, Denmark.
OrganisationIO Biotech
HeadquartersOle Maaløes Vej 3, Copenhagen, 2200, DK
IndustryBiotechnology
CEOMai-Britt Zocca

FAQs

What is IO Biotech share price today?

IO Biotech share price today is $0.00 as on . IO Biotech share today touched a day high of $0.01 and a low of $0.01.

What is the 52 week high and 52 week low for IO Biotech share?

IO Biotech share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . IO Biotech stock price today i.e. is trending at $0.00,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is IO Biotech's market capitalisation today?

IO Biotech market capitalisation is $0.00T as on .

How to invest in IO Biotech Stock (IOBTQ) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for IO Biotech on INDmoney app. Click on Buy button.

What is the minimum amount required to buy IO Biotech Stock (IOBTQ) from India?

Indian investors can start investing in IO Biotech (IOBTQ) shares with as little as ₹94.94000244140625 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.40 in IO Biotech stock (as per the Rupee-Dollar exchange rate as on ). Based on IO Biotech share’s latest price of $0.00 as on October 22, 2026 at 12:51 am IST, you will get 100000.0000 shares of IO Biotech. Learn more about fractional shares .